Dr. Kush Parmar has an impressive academic background, having worked on developmental genetics at Princeton University under the guidance of Nobel Laureate Eric F. Wieschaus.
In addition to his role at Syngene, he serves on the boards of several biotechnology companies, including Akouos, Entrada Therapeutics, GlycoEra, Homology Medicines, Rallybio, and Vor Biopharma.
He is also a founding member of the COVID R&D alliance, highlighting his significant contributions to research and development in the life sciences sector.
Kush Parmar is currently a Independent Director in Syngene International Ltd (as of Mar 2024).
Kush Parmar is serving the company - Syngene International Ltd at this position since 2022 for the last 3+ years.
Kush Parmar was Independent Director of Syngene International Ltd for 4 years from 2021 to 2024.
FAQ's related Kush Parmar
Who is Kush Parmar
Dr. Kush Parmar has an impressive academic background, having worked on developmental genetics at Princeton University under the guidance of Nobel Laureate Eric F. Wieschaus. In addition to his role at Syngene, he serves on the boards of several biotechnology companies, including Akouos, Entrada Therapeutics, GlycoEra, Homology Medicines, Rallybio, and Vor Biopharma. He is also a founding member of the COVID R&D alliance, highlighting his significant contributions to research and development in the life sciences sector.
Which companies does Kush Parmar serve as a board member for?
Kush Parmar serves as a board member for: Syngene International Ltd
What positions has Kush Parmar held in his/her career?
Throughout their career, Kush Parmar has held key positions such as Independent Director, contributing to the growth and success of each company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.